Combined with SLT can promote the production of ROS, p53 can be activated by ROS, so SLT can activate ROS/p53 to regulate ovarian cancer progression, which can be reversed by the effect of inhibiting ROS by NAC treatment. The gene discussed is TP53; the disease is ovarian carcinoma.